New topical therapy trial offers hope for 'Butterfly Skin' wound healing

NCT ID NCT07230223

Summary

This early-stage clinical trial is testing whether a topical gel called EV.FV can help heal wounds in people with dystrophic epidermolysis bullosa, a severe genetic skin condition. The treatment uses tiny particles from stem cells to deliver healing signals directly to the skin. Researchers will enroll 20 participants to check if the treatment is safe and if it helps close wounds and reduce pain.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for WOUND HEAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Alzahra Hospital

    RECRUITING

    Isfahan, Iran

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.